SNC
GSK icon

Stifel Nicolaus & Co’s GSK GSK Stock Holding History

Stifel Nicolaus & Co’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$21.5M Buy
342,070
+19,544
+6% +$1.26M 0.36% 79
2013
Q2 		$20.1M Buy
+322,526
New +$20.5M 0.36% 69

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Stifel Nicolaus & Co's GSK Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its GSK (GSK) stake by 6.1% in Q3 2013, buying an estimated $1.26M and bringing the position to 342,070 shares worth $21.5M. The position accounts for 0.36% of the portfolio, ranked #79.

Stifel Nicolaus & Co first reported a position in GSK in Q2 2013 and has held it in 2 quarters since. 635 funds tracked by Wall St. Rank hold GSK as of Q3 2013.

  • Stifel Nicolaus & Co held 342,070 shares of GSK worth $21.5M as of Q3 2013.
  • Stifel Nicolaus & Co bought 19,544 GSK shares in Q3 2013, an estimated $1.26M.
  • GSK made up 0.36% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #79 holding.
  • Stifel Nicolaus & Co first reported a position in GSK in Q2 2013 and has held it in 2 quarters since.
  • 635 funds tracked by Wall St. Rank held GSK as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.